Phase I study of the selective Aurora A kinase inhibitor MLN8054 in patients with advanced solid tumors: Safety, pharmacokinetics, and pharmacodynamics

Teresa Macarulla, Andres Cervantes, Elena Elez, Edith Rodríguez-Braun, José Baselga, Susana Roselló, Gemma Sala, Inma Blasco, Hadi Danaee, Yih Lee, Jeffrey Ecsedy, Vaishali Shinde, Arijit Chakravarty, Douglas Bowman, Hua Liu, Omar Eton, Howard Fingert, Josep Tabernero

Research output: Contribution to journalArticleResearchpeer-review

59 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase I study of the selective Aurora A kinase inhibitor MLN8054 in patients with advanced solid tumors: Safety, pharmacokinetics, and pharmacodynamics'. Together they form a unique fingerprint.

Medicine & Life Sciences